Kevin Tansley was appointed to the Trinity Biotech PLC board.
The company did not provide additional details in its securities filing.
Discover more about S&P Global’s offerings
Trinity Biotech appoints director
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Essential IR Insights Newsletter - Summer July-August 2023
Insight Weekly: Climate law faces hurdles; US borrowing surges; banks revise uninsured deposits
Kevin Tansley was appointed to the Trinity Biotech PLC board.
The company did not provide additional details in its securities filing.